{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:19:30Z","timestamp":1794543570645,"version":"4.9.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/01.ncc.0000281759.23823.82","type":"journal-article","created":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T04:03:17Z","timestamp":1184731397000},"page":"S10-S16","source":"Crossref","is-referenced-by-count":38,"title":["Ocular Toxicities of Epidermal Growth Factor Receptor Inhibitors and Their Management"],"prefix":"10.1097","volume":"30","author":[{"given":"Surendra","family":"Basti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-2-20210203","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.2004.10.182","article-title":"Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.","volume":"22","author":"Saltz","year":"2004","journal-title":"J Clin Oncol"},{"key":"R3-2-20210203","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2002.10.112","article-title":"ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial.","volume":"20","author":"Ranson","year":"2002","journal-title":"J Clin Oncol"},{"key":"R4-2-20210203","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1200\/JCO.2002.03.100","article-title":"Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.","volume":"20","author":"Baselga","year":"2002","journal-title":"J Clin Oncol"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.2004.11.057","article-title":"Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer.","volume":"22","author":"Perez-Soler","year":"2004","journal-title":"J Clin Oncol"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1200\/JCO.2004.06.075","article-title":"Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.","volume":"22","author":"Soulieres","year":"2004","journal-title":"J Clin Oncol"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02841860310006038","article-title":"Epidermal growth factor receptor inhibition induces trichomegaly.","volume":"42","author":"Dueland","year":"2003","journal-title":"Acta Oncol"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/annonc\/mdi300","article-title":"Trichomegaly of the eyelashes following treatment with cetuximab.","volume":"16","author":"Bouche","year":"2005","journal-title":"Ann Oncol"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/dji104","article-title":"Ocular toxicity related to cetuximab monotherapy in an advanced colorectal cancer patient.","volume":"97","author":"Tonini","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3816\/CCC.2006.n.040","article-title":"Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancer.","volume":"6","author":"Dranko","year":"2006","journal-title":"Clin Colorectal Cancer"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2004.06265.x","article-title":"Trichomegaly following treatment with gefitinib (ZD1839).","volume":"151","author":"Pascual","year":"2004","journal-title":"Br J Dermatol"},{"key":"R15-2-20210203","first-page":"236","article-title":"The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.","volume":"4","author":"Lacouture","year":"2006","journal-title":"J Support Oncol"},{"key":"R16-2-20210203","first-page":"3639","article-title":"Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition.","volume":"23","author":"Yano","year":"2003","journal-title":"Anticancer Res"},{"issue":"Pt 1","key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1242\/jcs.106.1.145","article-title":"Regional variation in distribution of EGF receptor in developing and adult corneal epithelium.","volume":"106","author":"Zieske","year":"1993","journal-title":"J Cell Sci"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003226-200101000-00016","article-title":"Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia.","volume":"20","author":"Liu","year":"2001","journal-title":"Cornea"}],"container-title":["Cancer Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.NCC.0000281759.23823.82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:48:47Z","timestamp":1786034927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002820-200707001-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ncc.0000281759.23823.82","relation":{},"ISSN":["0162-220X"],"issn-type":[{"value":"0162-220X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}